1. Petridou A, Siopi A, Mougios V. Exercise in the management of obesity. Metabolism 2019;92:163-9.
2. Azuma K, Heilbronn LK, Albu JB, Smith SR, Ravussin E, Kelley DE; Look AHEAD Adipose Research Group. Adipose tissue distribution in relation to insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2007;293:E435-42.
3. Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, Hill JO, Hubbard V, Kriska A, Stamm E, Pi-Sunyer FX; Diabetes Prevention Program Research Group. Relation of central adiposity and body mass index to the development of diabetes in the diabetes prevention program. Am J Clin Nutr 2008;87:1212-8.
4. Quiroga AD, Lehner R. Liver triacylglycerol lipases. Biochim Biophys Acta 2012;1821:762-9.
5. Dobrzyn P, Ntambi JM, Dobrzyn A. Stearoyl-CoA desaturase: a novel control pint of lipid metabolism and insulin sensitivity. Eur J Lipid Sci Technol 2008;110:93-100.
7. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, Sharma R, Hudgins LC, Ntambi JM, Friedman JM. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 2002;297:240-3.
8. Hawley JA, Hargreaves M, Joyner MJ, Zierath JR. Integrative biology of exercise. Cell 2014;159:738-49.
9. O’Gorman DJ, Krook A. Exercise and the treatment of diabetes and obesity. Endocrinol Metab Clin North Am 2008;37:887-903.
11. Yasari S, Prud’homme D, Wang D, Jankowski M, Levy E, Gutkowska J, Lavoie JM. Exercise training decreases hepatic SCD1 gene expression and protein content in rats. Mol Cell Biochem 2010;335:291-9.
12. Zhu X, Bian H, Wang L, Sun X, Xu X, Yan H, Xia M, Chang X, Lu Y, Li Y, Xia P, Li X, Gao X. Berberine attenuates nonalcoholic hepatic steatosis through the ampk-srebp-1c-SCD1 pathway. Free Radic Biol Med 2019;141:192-204.
13. Ortinau LC, Pickering RT, Nickelson KJ, Stromsdorfer KL, Naik CY, Haynes RA, Bauman DE, Rector RS, Fritsche KL, Perfield JW 2nd. Sterculic oil, a natural SCD1 inhibitor, improves glucose tolerance in obese ob/ob Mice. ISRN Endocrinol 2012;2012:947323.
14. Escande C, Nin V, Pirtskhalava T, Chini CC, Tchkonia T, Kirkland JL, Chini EN. Deleted in breast cancer 1 limits adipose tissue fat accumulation and plays a key role in the development of metabolic syndrome phenotype. Diabetes 2015;64:12-22.
16. Baldini SF, Wavelet C, Hainault I, Guinez C, Lefebvre T. The nutrient-dependent O-GlcNAc modification controls the expression of liver fatty acid synthase. J Mol Biol 2016;428:3295-304.
17. Su T, Huang C, Yang C, Jiang T, Su J, Chen M, Fatima S, Gong R, Hu X, Bian Z, Liu Z, Kwan HY. Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity. Pharmacol Res 2020;152:104586.
18. Després JP, Lamarche B. Low-intensity endurance exercise training, plasma lipoproteins and the risk of coronary heart disease. J Intern Med 1994;236:7-22.
19. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2001;286:1218-27.
20. Gioscia-Ryan RA, Clayton ZS, Zigler MC, Richey JJ, Cuevas LM, Rossman MJ, Battson ML, Ziemba BP, Hutton DA, VanDongen NS, Seals DR. Lifelong voluntary aerobic exercise prevents ageand Western diet-induced vascular dysfunction, mitochondrial oxidative stress and inflammation in mice. J Physiol 2021;599:911-25.
22. Roden M, Ludwig C, Nowotny P, Schneider B, Clodi M, Vierhapper H, Roden A, Waldhäusl W. Relative hypoleptinemia in patients with type 1 and type 2 diabetes mellitus. Int J Obes Relat Metab Disord 2000;24:976-81.